Injections of semaglutide were associated with significant improvement in cognitive function in people living with HIV (PWH), ...

The use of GLP-1 receptor agonists, like semaglutide, to treat type 2 diabetes is not associated with an increased risk of ...

People who can't afford the name-brand drugs have been flocking to compounded versions, which are available at a fraction of ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

While more research is needed, experts consider semaglutide a promising development in addressing alcohol addiction.

Neoadjuvant semaglutide before metabolic and bariatric surgery (MBS) is not beneficial in terms of weight loss.

There are early and suggestive data that GLP-1 drugs reduce alcohol cravings. A large cohort of people with alcohol use ...

A new study suggests that semaglutide, a drug commonly used to treat diabetes, may help protect the brain from the effects of ...

A phase 2 trial shows significant reduction in drinks per drinking day and weekly alcohol craving with low-dose semaglutide. HealthDay News — Low-dose semaglutide seems to reduce craving and certain ...

Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...

Please provide your email address to receive an email when new articles are posted on . Semaglutide and tirzepatide were the least cost-effective of four obesity drugs examined in a ...

Administration of semaglutide before metabolic and bariatric surgery does not confer benefits for overall weight loss, ...